Showing results (341-350 of 461) with videos related to

Sort By:
Pageof 47
Nature Reviews. Disease Primers|February 18, 2022
Cancer-associated venous thromboembolismAlok A Khorana, Nigel Mackman, Anna Falanga, et al.
Thrombosis and Haemostasis|February 26, 2004
Platelet kinetics and scintigraphic imaging in thrombocytopenic malaria patientsGeorgios Karanikas, Konstantin Zedwitz-Liebenstein, Harald Eidherr, et al.
The Journal of Rheumatology|March 3, 2005
Inflammation in patients with lupus anticoagulant and implications for thrombosisThomas Sailer, Rainer Vormittag, Ingrid Pabinger, et al.
Blood|May 25, 2016
FVIII-binding IgG modulates FVIII half-life in patients with severe and moderate hemophilia A without inhibitorsChristoph J Hofbauer, Sylvia Kepa, Michael Schemper, et al.
Hematology (Amsterdam, Netherlands)|July 5, 2025
A-SURE: intra-patient comparison of prophylactic effectiveness of a recombinant factor VIII Fc fusion protein versus standard half-life factor VIII in hemophilia AJohannes Oldenburg, Charles Hay, Flora Peyvandi, et al.
Haematologica|March 8, 2005
Mutation of the prothrombin gene and thrombotic events in patients with polycythemia vera or essential thrombocythemia: a cohort studyHeinz Gisslinger, Marcus Müllner, Ingrid Pabinger, et al.
Respiration; International Review of Thoracic Diseases|February 24, 2022
Outpatient Pulmonary Rehabilitation in Patients with Long COVID Improves Exercise Capacity, Functional Status, Dyspnea, Fatigue, and Quality of LifeStephan Nopp, Florian Moik, Frederikus A Klok, et al.
JACC. Cardiooncology|January 11, 2024
Cancer-Associated Thrombosis: Trends in Clinical Features, Treatment, and Outcomes From 2001 to 2020Laurent Bertoletti, Olga Madridano, David Jiménez, et al.
Research and Practice in Thrombosis and Haemostasis|October 19, 2019
Needs and challenges among physicians and researchers in thrombosis and hemostasis: Results from an international studySuzanne Murray, Claire McLintock, Patrice Lazure, et al.
Thrombosis and Haemostasis|September 28, 2012
Efficacy and safety of prophylaxis with once-weekly BAY 79-4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients. A randomised, active-controlled, double-blind studyJerry Powell, Uri Martinowitz, Jerzy Windyga, et al.
Pageof 47